Experts Debate Whether IRA Provisions Stifle Pharma Innovation at Senate Hearing
Rena Conti, quoted in MedPage Today, September 18, 2024.
Rena Conti, quoted in MedPage Today, September 18, 2024.
Timothy Simcoe, TPRI Faculty Director’s, research cited in Marketing Brew, September 18, 2024.
James Bessen, TPRI Executive Director, interviewed in Value Investing with Legends podcast, PlayerFM, May 31, 2024.
Rena Conti, TPRI Faculty Director quoted in Stateline, May 28, 2024.
Podcast with Julien Mc Donald-Guimond interviewing TPRI’s Executive Director, James Bessen, on why automation sometimes increases employment and decreases it at other time.
La planche à billets ASDEQ , May 8, 2024.
Eric J. Evans, Alexandre Meyer, Rena M. Conti’s paper “Sizing A Market Entry Reward for the Development of New Antibiotics” M-RCBG Associate Working Paper No. 232, Mossavar-Rahmani Center for Business & Government, Harvard Kennedy School, May 2024.
James Bessen, TPRI Executive Director, quoted in “The US steel industry is going through a rough patch. How did it get there?” Marketplace, March 14, 2024.
Matthew Vogel, Rena M. Conti, and Amitabh Chandra’s article “Biopharma Venture Capital And The Inflation Reduction Act”
Health Affairs Forefront, March 5, 2024.
Keith Ericson’s article “Innovation vs Affordability: Navigating Pharmaceutical Payment Dilemmas”
Insights@Questrom, February 7, 2024.
Mark V. Pauly, Debra M. Lederman, and Rena M. Conti’s article “The Inflation Reduction Act Coinsurance Glitch”
Health Affairs Forefront, January 17, 2024.